Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
dexrazoxanhydrochlorid 250 mg hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexrazoxane (substance) |
Inferred relationship |
Some |
|
dexrazoxanhydrochlorid 500 mg hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexrazoxane (substance) |
Inferred relationship |
Some |
|
dexrazoxanhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexrazoxane (substance) |
Inferred relationship |
Some |
|
Product containing dexrazoxane (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexrazoxane (substance) |
Inferred relationship |
Some |
1 |
Dexrazoxane hydrochloride (substance) |
Is a |
False |
Dexrazoxane (substance) |
Inferred relationship |
Some |
|
Dexrazoxane hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dexrazoxane (substance) |
Inferred relationship |
Some |
|
Product containing only dexrazoxane (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexrazoxane (substance) |
Inferred relationship |
Some |
1 |
Dexrazoxane-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexrazoxane (substance) |
Inferred relationship |
Some |
1 |
Product containing only dexrazoxane in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexrazoxane (substance) |
Inferred relationship |
Some |
1 |
Dexrazoxane (as dexrazoxane hydrochloride) 500 mg powder for solution for infusion vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexrazoxane (substance) |
Inferred relationship |
Some |
1 |